Gurnet Point Capital invests in scientifically de-risked life science products to bring safe and effective treatments to market, positively impacting patients and generating outsized investor returns.  They drive these returns through our active ownership approach, taking control positions to apply the skills and experience of their differentiated investment and operations team that efficiently move our portfolio companies through key value inflection points.​